AllianceBernstein
ACOR

AllianceBernstein’s Acorda Therapeutics ACOR Stock Holding History

AllianceBernstein’s Portfolio ACOR Stock Details ACOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-667
Closed -$75K – 3277
2020
Q1 		$75K Buy
667
+1
+0.2% +$197 ﹤0.01% 3011
2019
Q4 		$163K Sell
666
-3
-0.4% -$757 ﹤0.01% 2962
2019
Q3 		$231K Sell
669
-217
-24% -$118K ﹤0.01% 2895
2019
Q2 		$816K Buy
886
+288
+48% +$354K ﹤0.01% 2401
2019
Q1 		$953K Hold
598
– – ﹤0.01% 2252
2018
Q4 		$1.12M Sell
598
-42
-7% -$91.4K ﹤0.01% 2148
2018
Q3 		$1.51M Hold
640
– – ﹤0.01% 2123
2018
Q2 		$2.2M Buy
640
+124
+24% +$380K ﹤0.01% 1840
2018
Q1 		$1.47M Sell
516
-325
-39% -$973K ﹤0.01% 2045
2017
Q4 		$2.16M Buy
841
+244
+41% +$694K ﹤0.01% 1804
2017
Q3 		$1.69M Hold
597
– – ﹤0.01% 1963
2017
Q2 		$1.41M Sell
597
-705
-54% -$1.4M ﹤0.01% 2092
2017
Q1 		$3.28M Buy
1,302
+804
+161% +$2.31M ﹤0.01% 1453
2016
Q4 		$1.12M Sell
498
-26
-5% -$61.8K ﹤0.01% 2211
2016
Q3 		$1.31M Sell
524
-467
-47% -$1.39M ﹤0.01% 2070
2016
Q2 		$3.03M Buy
991
+364
+58% +$1.18M ﹤0.01% 1364
2016
Q1 		$1.99M Buy
627
+11
+2% +$45.7K ﹤0.01% 1622
2015
Q4 		$3.16M Sell
616
-19
-3% -$83K ﹤0.01% 1290
2015
Q3 		$2.02M Sell
635
-1
-0.2% -$3.88K ﹤0.01% 1638
2015
Q2 		$2.54M Hold
636
– – ﹤0.01% 1593
2015
Q1 		$2.54M Hold
636
– – ﹤0.01% 1557
2014
Q4 		$3.12M Hold
636
– – ﹤0.01% 1411
2014
Q3 		$2.58M Sell
636
-61
-9% -$229K ﹤0.01% 1521
2014
Q2 		$2.82M Hold
697
– – ﹤0.01% 1518
2014
Q1 		$3.17M Sell
697
-61
-8% -$247K ﹤0.01% 1387
2013
Q4 		$2.66M Hold
758
– – ﹤0.01% 1512
2013
Q3 		$3.12M Hold
758
– – ﹤0.01% 1368
2013
Q2 		$3M Buy
+758
New +$3.12M ﹤0.01% 1330

Other funds holding ACOR

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

AllianceBernstein's ACOR Position: Q2 2020 in Review

AllianceBernstein sold out of Acorda Therapeutics (ACOR) in Q2 2020, closing a stake of 667 shares — an estimated $75K sold.

AllianceBernstein first reported a position in ACOR in Q2 2013 and held it in 28 quarters. The position peaked at $3.28M in Q1 2017. 79 funds tracked by Wall St. Rank hold ACOR as of Q2 2020.

  • AllianceBernstein reported no remaining Acorda Therapeutics position as of Q2 2020 after selling out during the quarter.
  • AllianceBernstein sold 667 Acorda Therapeutics shares in Q2 2020, an estimated $75K.
  • AllianceBernstein first reported a position in Acorda Therapeutics in Q2 2013 and held it in 28 quarters.
  • AllianceBernstein's Acorda Therapeutics position peaked at $3.28M in Q1 2017.
  • 79 funds tracked by Wall St. Rank held Acorda Therapeutics as of Q2 2020.

Based on AllianceBernstein's 13F filing for Q2 2020, filed 13 Aug 2020.